TNF and rheumatoid arthritis: The anti-SARS-CoV-2 IgG level after the first dose of vaccination was markedly lower in RA patients who received non-anti-TNF-α bDMARDs and JAK inhibitor when compared with participants who received csDMARDs (p=0.004).